Carles is Head of Business Development at Curapath. He holds a PhD in Organic Chemistry and an MSc in Applied and Pharmacological Chemistry, with over +10 years of experience in the nanomedicine field. Since joining Curapath as a Project Manager in 2018, He has been a key player in expanding the company’s capabilities in non-viral delivery systems. With +15 high-impact publications and +5 patents, he brings both scientific innovation and strategic foresight to the team delivering innovative solutions aligned with both market demands and Curapath’s strategic vision. His leadership has been crucial in managing programs from early development through clinical stages, offering tailored solutions that address the specific needs of both early adopters and late-stage customers. By providing innovative products and services, he ensured a smooth transition from concept to market, helping customers at advanced stages maximize value and meet their clinical and commercialization goals. In his current role, he heads Curapath’s Sales and Business Development team, driving business growth by capturing new opportunities and guiding the company’s strategic initiatives to meet the evolving demands of late-stage customers.